Aspartate beta-Hydroxylase (ASPH) (Middle Region) Peptide
Quick Overview for Aspartate beta-Hydroxylase (ASPH) (Middle Region) Peptide (ABIN973520)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- PVEDSQVIVE EVSIFPVEEQ QEVPPETNRK TDDPEQKAKV KKKKPKLLNK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ASPH Antibody(ARP34194_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Aspartate beta Hydroxylase (ASPH) (Aspartate beta-Hydroxylase (ASPH))
-
Background
-
ASPH is thought to play an important role in calcium homeostasis. Alternative splicing of this gene results in five transcript variants which vary in protein translation, the coding of catalytic domains, and tissue expression. Variation among these transcripts impacts their functions which involve roles in the calcium storage and release process in the endoplasmic and sarcoplasmic reticulum as well as hydroxylation of aspartic acid and asparagine in epidermal growth factor-like domains of various proteins.
Alias Symbols: BAH, CASQ2BP1, HAAH, JCTN, junctin, AAH
Protein Interaction Partner: TRDN,SQSTM1
Protein Size: 758 -
Molecular Weight
- 86 kDa
-
Gene ID
- 444
-
NCBI Accession
- NM_004318, NP_004309
-
UniProt
- Q12797
Target
-